Related Experiment Video
Updated: Jan 29, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
A non-functional neoepitope specific CD8+ T-cell response induced by tumor derived antigen exposure in vivo
Mathias Vormehr1,2, Katharina Reinhard1, Renata Blatnik3
1Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany.
Abstract:
Cancer-associated mutations, mostly single nucleotide variations, can act as neoepitopes and prime targets for effective anti-cancer T-cell immunity. T cells recognizing cancer mutations are critical for the clinical activity of immune checkpoint blockade (ICB) and they are potent vaccine antigens. High frequencies of mutation-specific T cells are rarely spontaneously induced. Hence, therapies that broaden the tumor specific T-cell response are of interest. Here, we analyzed neoepitope-specific CD8+ T-cell responses mounted either spontaneously or after immunotherapy regimens, which induce local tumor inflammation and cell death, in mice bearing tumors of the widely used colon carcinoma cell line CT26. A comprehensive immune reactivity screening of 2474 peptides covering 628 transcribed CT26 point mutations was conducted. All tested treatment regimens were found to induce a single significant CD8+ T-cell response against a non-synonymous D733A point mutation in the Smc3 gene. Surprisingly, even though Smc3 D733A turned out to be the immune-dominant neoepitope in CT26 tumor bearing mice, neither T cells specific for this neoepitope nor their T cell receptors (TCRs) were able to recognize or lyse tumor cells. Moreover, vaccination with the D733A neoepitope did not result in anti-tumoral activity despite induction of specific T cells. This is to our knowledge the first report that neoepitope specific CD8+ T cells primed by tumor-released antigen exposure in vivo can be functionally irrelevant.
Insights
Cancer mutations can create neoepitopes that prime T-cell immunity. However, even dominant neoepitope-specific T cells may not effectively target tumors or mediate anti-cancer activity.
Area of Science:
- Immunology
- Cancer Research
- Molecular Biology
Background:
- Cancer mutations can serve as neoepitopes, eliciting T-cell responses crucial for anti-cancer immunity and immune checkpoint blockade (ICB).
- Therapies aiming to broaden tumor-specific T-cell responses are of significant interest due to the limited spontaneous induction of mutation-specific T cells.
Purpose of the Study:
- To investigate neoepitope-specific CD8+ T-cell responses in mice with CT26 colon carcinoma tumors.
- To evaluate the functional relevance of T-cell responses against a specific neoepitope after various immunotherapy regimens.
Main Methods:
- Screening of 2474 peptides covering 628 CT26 point mutations for immune reactivity.
- Analysis of CD8+ T-cell responses induced spontaneously or post-immunotherapy.
- Assessment of T-cell receptor (TCR) recognition and tumor cell lysis.
- Evaluation of anti-tumoral activity following vaccination with a specific neoepitope.
Main Results:
- All tested immunotherapies induced a significant CD8+ T-cell response against the Smc3 D733A neoepitope.
- Despite being the immune-dominant neoepitope, Smc3 D733A-specific T cells and their TCRs could not recognize or lyse CT26 tumor cells.
- Vaccination with the D733A neoepitope failed to induce anti-tumoral activity, even with specific T-cell induction.
Conclusions:
- The study reports the first instance of neoepitope-specific CD8+ T cells, primed by tumor antigen exposure in vivo, being functionally irrelevant.
- This finding highlights a critical disconnect between neoepitope recognition and effective anti-tumor immunity, challenging assumptions in cancer immunotherapy.
More Related Videos
10:44A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
Published on: August 9, 2019
10:57Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
Published on: October 24, 2019
Related Concept Videos
The Derivative as a Function
Cell Specific Gene Expression
Derivatives of the Trigonometric Functions
Derivatives of Logarithmic Functions
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Derivatives of Simple Functions